• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

摄入含有麻黄的营养补充剂后麻黄碱的药代动力学。

Ephedrine pharmacokinetics after the ingestion of nutritional supplements containing Ephedra sinica (ma huang).

作者信息

Gurley B J, Gardner S F, White L M, Wang P L

机构信息

Department of Pharmaceutics, University of Arkansas for Medical Sciences, College of Pharmacy, Little Rock 72205, USA.

出版信息

Ther Drug Monit. 1998 Aug;20(4):439-45. doi: 10.1097/00007691-199808000-00015.

DOI:10.1097/00007691-199808000-00015
PMID:9712471
Abstract

Nutritional supplements containing Ephedra sinica (ma huang), a botanical source of ephedrine alkaloids, have been linked to several episodes of ephedrine toxicity and at least 17 deaths, yet these products remain unregulated. Ten subjects were enrolled in a randomized, crossover study aimed at characterizing the pharmacokinetics of ephedrine after the ingestion of three commercially available ma huang products compared with a 25-mg ephedrine capsule. Pharmacokinetic parameters for botanical ephedrine were similar to those for synthetic ephedrine hydrochloride. Gender-based comparisons of Vss/F and CL/F revealed higher values for women than for men (Vss/F, 3.49 +/- 1.04 vs 2.98 +/- 0.73 l/kg; CL/F, 0.48 +/- 0.11 vs 0.37 +/- 0.11 l/hour x kg). The current study suggests that the increased incidence of ma huang toxicity does not stem from differences in the absorption of botanical ephedrine compared with synthetic ephedrine; rather, it results from accidental overdose often prompted by exaggerated off-label claims and a belief that "natural" medicinal agents are inherently safe.

摘要

含有麻黄碱生物碱植物来源的麻黄(麻黄)的营养补充剂,已与多起麻黄碱中毒事件以及至少17例死亡病例相关联,但这些产品仍未得到监管。十名受试者参与了一项随机交叉研究,旨在比较摄入三种市售麻黄产品后麻黄碱的药代动力学与25毫克麻黄碱胶囊的药代动力学。植物性麻黄碱的药代动力学参数与合成盐酸麻黄碱的药代动力学参数相似。基于性别的Vss/F和CL/F比较显示,女性的值高于男性(Vss/F,3.49±1.04对2.98±0.73升/千克;CL/F,0.48±0.11对0.37±0.11升/小时×千克)。当前研究表明,麻黄中毒发生率的增加并非源于植物性麻黄碱与合成麻黄碱在吸收方面的差异;相反,它是由夸大的非标签声明以及认为“天然”药物本质上安全的观念常常引发的意外过量用药导致的。

相似文献

1
Ephedrine pharmacokinetics after the ingestion of nutritional supplements containing Ephedra sinica (ma huang).摄入含有麻黄的营养补充剂后麻黄碱的药代动力学。
Ther Drug Monit. 1998 Aug;20(4):439-45. doi: 10.1097/00007691-199808000-00015.
2
Ephedrine-type alkaloid content of nutritional supplements containing Ephedra sinica (Ma-huang) as determined by high performance liquid chromatography.通过高效液相色谱法测定含麻黄的营养补充剂中麻黄碱类生物碱的含量。
J Pharm Sci. 1998 Dec;87(12):1547-53. doi: 10.1021/js9801844.
3
Pharmacokinetics and cardiovascular effects of ma-huang (Ephedra sinica) in normotensive adults.麻黄(草麻黄)在血压正常成年人中的药代动力学及心血管效应
J Clin Pharmacol. 1997 Feb;37(2):116-22. doi: 10.1002/j.1552-4604.1997.tb04769.x.
4
Determination of ephedrine alkaloids in botanicals and dietary supplements by HPLC-UV: collaborative study.采用高效液相色谱-紫外检测法测定植物药和膳食补充剂中的麻黄碱生物碱:协同研究。
J AOAC Int. 2004 Jan-Feb;87(1):1-14.
5
Content versus label claims in ephedra-containing dietary supplements.含麻黄属植物膳食补充剂中的成分与标签声明对比
Am J Health Syst Pharm. 2000 May 15;57(10):963-9. doi: 10.1093/ajhp/57.10.963.
6
Cytotoxicity assessment of Ma-huang (Ephedra) under different conditions of preparation.不同制备条件下麻黄的细胞毒性评估。
Toxicol Sci. 2000 Aug;56(2):424-30. doi: 10.1093/toxsci/56.2.424.
7
Chiral gas chromatographic determination of ephedrine-type alkaloids in dietary supplements containing Má Huáng.手性气相色谱法测定含麻黄的膳食补充剂中麻黄碱类生物碱的含量。
J AOAC Int. 1997 Mar-Apr;80(2):303-15.
8
Extract versus herb: effect of formulation on the absorption rate of botanical ephedrine from dietary supplements containing Ephedra (ma huang).提取物与草药:制剂对含麻黄(麻黄)的膳食补充剂中植物性麻黄碱吸收速率的影响。
Ther Drug Monit. 2000 Aug;22(4):497. doi: 10.1097/00007691-200008000-00021.
9
Concentrations of ephedra alkaloids and caffeine in commercial dietary supplements.商业膳食补充剂中麻黄生物碱和咖啡因的含量
J Anal Toxicol. 2004 Apr;28(3):145-51. doi: 10.1093/jat/28.3.145.
10
Pharmacology of ephedra alkaloids and caffeine after single-dose dietary supplement use.单次服用膳食补充剂后麻黄生物碱和咖啡因的药理学。
Clin Pharmacol Ther. 2002 Jun;71(6):421-32. doi: 10.1067/mcp.2002.124523.

引用本文的文献

1
Efficacy and safety of ephedra-containing oral medications: a systematic review, meta-analysis, and exploratory dose-response analysis for weight reduction.含麻黄碱口服药物的疗效与安全性:一项关于减肥的系统评价、荟萃分析及探索性剂量反应分析
Front Pharmacol. 2024 Oct 30;15:1397247. doi: 10.3389/fphar.2024.1397247. eCollection 2024.
2
Commonly Used Dietary Supplements on Coagulation Function during Surgery.手术期间常用膳食补充剂对凝血功能的影响
Medicines (Basel). 2015 Sep;2(3):157-185. doi: 10.3390/medicines2030157. Epub 2015 Jul 27.
3
Gender-Dependent Pharmacokinetics of Veratramine in Rats: In Vivo and In Vitro Evidence.
藜芦胺在大鼠体内的性别依赖性药代动力学:体内和体外证据
AAPS J. 2016 Mar;18(2):432-44. doi: 10.1208/s12248-016-9870-9. Epub 2016 Jan 20.
4
Bioactive Markers Based Pharmacokinetic Evaluation of Extracts of a Traditional Medicinal Plant, Piper sarmentosum.基于生物活性标志物的传统药用植物荜茇提取物的药代动力学评价。
Evid Based Complement Alternat Med. 2011;2011:980760. doi: 10.1093/ecam/nep143. Epub 2011 Jun 23.
5
Ephedra and its application to sport performance: another concern for the athletic trainer?麻黄及其在运动表现中的应用:运动训练师的另一个关注点?
J Athl Train. 2001 Oct;36(4):420-4.
6
Syncope and atypical chest pain in an intercollegiate wrestler: a case report.大学生摔跤运动员晕厥和非典型胸痛:病例报告。
J Athl Train. 1999 Jul;34(3):263-6.
7
Coronary thrombosis related to use of Xenadrine RFA.与使用Xenadrine RFA相关的冠状动脉血栓形成。
Tex Heart Inst J. 2005;32(1):74-7.
8
Mechanistic pharmacokinetic modelling of ephedrine, norephedrine and caffeine in healthy subjects.健康受试者中麻黄碱、去甲麻黄碱和咖啡因的药代动力学机制建模
Br J Clin Pharmacol. 2005 Mar;59(3):335-45. doi: 10.1111/j.1365-2125.2005.02254.x.
9
Caffeine and ephedrine: physiological, metabolic and performance-enhancing effects.咖啡因与麻黄碱:生理、代谢及增强运动表现的作用
Sports Med. 2004;34(13):871-89. doi: 10.2165/00007256-200434130-00002.
10
Modelling the cardiovascular effects of ephedrine.麻黄碱心血管效应的建模
Br J Clin Pharmacol. 2004 May;57(5):552-62. doi: 10.1111/j.1365-2125.2003.02062.x.